---
figid: PMC5407862__conc-24-111f1
figlink: /pmc/articles/PMC5407862/figure/f1-conc-24-111/
number: F1
caption: Mechanisms of resistance to epidermal growth factor receptor (EGFR) tyrosine
  kinase inhibitors (TKIs) can be broadly categorized into central nervous system
  (CNS) sanctuary, target alteration, bypass pathway activation, histologic transformation,
  and downstream pathway activation. Ampl = amplification; gold star = mutation; rebound
  effect = upregulation of tyrosine kinases after ERK or PI3K pathway inhibition;
  EMT = epithelial-to-mesenchymal transition.
pmcid: PMC5407862
papertitle: 'Management of EGFR-mutated non-small-cell lung cancer: practical implications
  from a clinical and pathology perspective.'
reftext: M. Cabanero, et al. Curr Oncol. 2017 Apr;24(2):111-119.
pmc_ranked_result_index: '110754'
pathway_score: 0.6834016
filename: conc-24-111f1.jpg
figtitle: 'Management of EGFR-mutated non-small-cell lung cancer: practical implications
  from a clinical and pathology perspective.'
year: '2017'
organisms: Homo sapiens
ndex: b1be50b4-de9e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5407862__conc-24-111f1.html
  '@type': Dataset
  description: Mechanisms of resistance to epidermal growth factor receptor (EGFR)
    tyrosine kinase inhibitors (TKIs) can be broadly categorized into central nervous
    system (CNS) sanctuary, target alteration, bypass pathway activation, histologic
    transformation, and downstream pathway activation. Ampl = amplification; gold
    star = mutation; rebound effect = upregulation of tyrosine kinases after ERK or
    PI3K pathway inhibition; EMT = epithelial-to-mesenchymal transition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - MAPK1
  - MAPK3
  - ERBB2
  - PIK3R4
  - PIK3CA
  - BRAF
  - GAS6
  - NRAS
  - PIK3CD
  - AKT3
  - HRAS
  - KRAS
  - RAF1
  - HGF
  - PIK3CB
  - MAP2K1
  - MAP2K2
  - MET
  - PIK3R5
  - AKT2
  - ARAF
  - PTEN
  - PIK3CG
  - AKT1
  - PIK3R6
  - PIK3R3
  - MTOR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: GAS6
  symbol: GAS6
  source: hgnc_symbol
  hgnc_symbol: GAS6
  entrez: '2621'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: MAPK1
  symbol: MAPK1
  source: hgnc_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: mTor
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5407862__F1
redirect_from: /figures/PMC5407862__F1
figtype: Figure
---
